SK Chemicals’ joint sales and marketing agreement of SKY Zoster with Daewoong
‘SKY Zoster,’ the first shingles vaccine developed by an Korean pharmaceutical company and become a blockbuster medicinal drug with collective sales of KRW 10 billion this year, will have more active marketing activities in the market.
SK Chemicals(CEO Man-Hoon Park) announced conclusion of a jo...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.